2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-
- CAS No.
- 454234-24-3
- Chemical Name:
- 2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-
- Synonyms
- JAK3-IN-14;JAK3-IN-14, 10 mM in DMSO;2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)-;(3Z)-5-(pyridin-3-yl)-3-[(1H-pyrrol-2-yl)methylidene]-2,3-dihydro-1H-indol-2-one
- CBNumber:
- CB99106281
- Molecular Formula:
- C18H13N3O
- Molecular Weight:
- 287.32
- MDL Number:
- MOL File:
- 454234-24-3.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Boiling point | 607.1±55.0 °C(Predicted) |
|---|---|
| Density | 1.332±0.06 g/cm3(Predicted) |
| pka | 12.26±0.20(Predicted) |
| form | Solid |
| color | Yellow to orange |
| FDA UNII | 5KU2EZ77LX |
2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0890211 | JAK3-IN-14 99.32% | 454234-24-3 | 5mg | $596 | 2026-06-04 | Buy |
| ChemScene | CS-0890211 | JAK3-IN-14 99.32% | 454234-24-3 | 10mg | $867 | 2026-06-04 | Buy |
| aablocks | AA01I61U | 3-((1H-Pyrrol-2-yl)methylene)-5-(pyridin-3-yl)indolin-2-one 98+% | 454234-24-3 | 25mg | $101 | 2026-05-30 | Buy |
| aablocks | AA01I61U | 3-((1H-Pyrrol-2-yl)methylene)-5-(pyridin-3-yl)indolin-2-one 98+% | 454234-24-3 | 50mg | $171 | 2026-05-30 | Buy |
| aablocks | AA01I61U | 3-((1H-Pyrrol-2-yl)methylene)-5-(pyridin-3-yl)indolin-2-one 98+% | 454234-24-3 | 100mg | $290 | 2026-05-30 | Buy |
2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)- Chemical Properties, Uses, Production
Uses
JAK3-IN-14 (compound 1) is a potent JAK3 inhibitor, with IC50 values of 38 and 600 nM for JAK3 and JAK2, respectively. JAK3-IN-14 shows inhibitory of IL-4 and IL-3 induced TF-1 cell proliferation, with IC50 values of 600 and 500 nM, respectively[1].
Definition
ChEBI: 5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-2-one is a member of indoles.
IC 50
JAK3: 38 nM (IC50); JAK2: 600 nM (IC50)
References
[1] Chen JJ, et al. Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5633-8. DOI:10.1016/j.bmcl.2006.08.022
2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)- Preparation Products And Raw materials
Raw materials
Preparation Products
2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Tianjin Kailiqi Biotechnology Co., Ltd. | 15076683720 | klq@cw-bio.com | China | 9778 | 55 |
| Shanghai Chaolan Chemical Technology Center | QQ:65489617 13301690235 | Sales@ATKchemical.com | China | 9729 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Beijing Boorsen Biotechnology Co., Ltd | 400-901-9800 18611424007 | cis@bioss.com.cn | China | 9185 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd | 025-5885952 15955137747 | sales@aikonchem.com | China | 8012 | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 13370042665 18916960931 | 2596183085@qq.com | China | 17234 | 58 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32997 | 60 |
View Latest Price from 2H-Indol-2-one, 1,3-dihydro-5-(3-pyridinyl)-3-(1H-pyrrol-2-ylmethylene)- manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | JAK3-IN-14
454234-24-3
|
$107.00-397.00 | 99.39% | 10g | TargetMol Chemicals Inc. |
-

- JAK3-IN-14
454234-24-3
- $107.00-397.00
- 99.39%
- TargetMol Chemicals Inc.




